TCBWMS
RNTX

Texas Capital Bank Wealth Management Services’s Rein Therapeutics RNTX Stock Holding History

Texas Capital Bank Wealth Management Services’s Portfolio RNTX Stock Details RNTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$356K Buy
273,625
+11,500
+4% +$14.3K 0.02% 249
2025
Q4 		$304K Buy
262,125
+235,954
+902% +$325K 0.02% 258
2025
Q3 		$30K Hold
26,171
– – ﹤0.01% 253
2025
Q2 		$36.6K Hold
26,171
– – ﹤0.01% 220
2025
Q1 		$46.3K Hold
26,171
– – ﹤0.01% 204
2024
Q4 		$60.2K Hold
26,171
– – 0.01% 158
2024
Q3 		$92.6K Hold
26,171
– – 0.01% 191
2024
Q2 		$72.5K Hold
26,171
– – 0.01% 191
2024
Q1 		$174K Buy
26,171
+10,398
+66% +$49.8K 0.02% 182
2023
Q4 		$48.1K Buy
+15,773
New +$30.8K 0.01% 198

Other funds holding RNTX

VC
Voss Capital Houston, Texas $1.88B AUM 1.03% 1-Year Est. Return
BCM
BIOS Capital Management Fort Worth, Texas $52.9M AUM 30.51% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
UOTTAIMCU
University of Texas/Texas AM Investment Management Co (UTIMCO) Austin, Texas $863M AUM 30.35% 1-Year Est. Return
CCC
Cable Car Capital San Francisco, California $289M AUM 26.33% 1-Year Est. Return
PM
Prosight Management Dallas, Texas $610M AUM 40.86% 1-Year Est. Return
SPC
Sigma Planning Corp Ann Arbor, Michigan $3.6B AUM 24.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
GS
Gagnon Securities New York $519M AUM 44.91% 1-Year Est. Return
SM
Senvest Management New York $3.01B AUM 35.7% 1-Year Est. Return

Texas Capital Bank Wealth Management Services's RNTX Position: Q1 2026 in Review

Texas Capital Bank Wealth Management Services increased its Rein Therapeutics (RNTX) stake by 4.4% in Q1 2026, buying an estimated $14.3K and bringing the position to 273,625 shares worth $356K. The position accounts for 0.02% of the portfolio, ranked #249.

Texas Capital Bank Wealth Management Services first reported a position in RNTX in Q4 2023 and has held it in 10 quarters since. 46 funds tracked by Wall St. Rank hold RNTX as of Q1 2026.

  • Texas Capital Bank Wealth Management Services held 273,625 shares of Rein Therapeutics worth $356K as of Q1 2026.
  • Texas Capital Bank Wealth Management Services bought 11,500 Rein Therapeutics shares in Q1 2026, an estimated $14.3K.
  • Rein Therapeutics made up 0.02% of Texas Capital Bank Wealth Management Services's portfolio in Q1 2026, its #249 holding.
  • Texas Capital Bank Wealth Management Services first reported a position in Rein Therapeutics in Q4 2023 and has held it in 10 quarters since.
  • 46 funds tracked by Wall St. Rank held Rein Therapeutics as of Q1 2026.

Based on Texas Capital Bank Wealth Management Services's 13F filing for Q1 2026, filed 11 May 2026.